跨专业药物评估对家庭护理患者用药质量的影响:随机对照干预研究
FIMA研究为随机对照试验,纳入≥65岁、每日≥6种药物且伴头晕、直立性低血压或近期跌倒的家庭护理患者512例,比较医生主导的跨专业药物评估与常规照护。6个月随访显示干预组肾脏功能受损、出血、抗胆碱能效应、便秘等用药风险及潜在不适当用药(PIMs)使用几率显著降低,但药物相互作用和药物数量无显著变化。
要点
- 跨专业药物评估可显著降低家庭护理老年患者的用药相关风险负荷。
- 干预减少了潜在不适当用药(Meds75+ D)的使用几率。
- 药物相互作用数量与总用药数量未见显著改变。
核心结论
- FIMA干预改善了家庭护理患者的用药质量,显著降低肾衰竭、抗胆碱能效应、出血、便秘风险及PIMs使用。
研究设计与样本
- FIMA研究为随机对照研究,比较医生主导的跨专业药物评估与常规照护。
- 研究在芬兰家庭护理机构开展,纳入≥65岁、每日≥6种药物且伴头晕、直立性低血压或近期跌倒的患者512例。
主要发现
- 家庭护理患者平均用药总数为15种。
- 干预组药物致肾功能损害(RENBASE D,P=.020)的几率显著降低。
- 干预组出血(PHARAO D,P=.001)、抗胆碱能效应(PHARAO D,P=.009)、便秘(PHARAO D,P=.003)的用药相关风险负荷几率显著降低。
- 干预组使用潜在不适当用药(Meds75+ D,P=.005)的几率显著降低。
- 药物相互作用或药物数量无显著变化。
关键数值与推荐
- 采用SFINX、RENBASE、PHARAO和Meds75+数据库评估用药质量,风险分类为A(无已知药理学或临床依据)、B(证据不足/不确定)、C(中度风险,可能有临床相关性)、D(高风险,最好避免)。
- 主要结局指标为6个月随访期间药物数量、药物相互作用、用药相关风险负荷及PIMs使用。
- 统计分析采用校正年龄、性别和结局基线水平的逻辑回归。
临床怎么用
- 对每日用药≥6种且伴头晕、直立性低血压或近期跌倒的家庭护理老年患者,可考虑实施医生主导的跨专业药物评估以改善用药质量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Multimorbidity and complex medications increase the risk of medication-related problems, especially in vulnerable home care patients. The objective of this study was to examine whether interprofessional medication assessment has an effect on medication quality among home care patients. DESIGN: The FIMA (Finnish Interprofessional Medication Assessment) study was a randomized, controlled study comparing physician-led interprofessional medication assessment and usual care. SETTING AND PARTICIPANTS: The FIMA study was conducted in home care settings in Finland. The participants were ≥65-year-old home care patients with ≥6 drugs daily, dizziness, orthostatic hypotension, or a recent fall. METHODS: Primary outcome measures over the 6-month follow-up were number of drugs, drug-drug-interactions, medication-related risk loads, and use of potentially inappropriate medications (PIMs) examined by SFINX, RENBASE, PHARAO, and Meds75+ databases. The databases classified information as follows: A (no known pharmacologic or clinical basis for an increased risk), B (evidence not available/uncertain), C (moderately increased risk which may have clinical relevance), and D (high risk, best to avoid). Logistic regression adjusted for age, sex, and the baseline level of the outcome measure served as statistical methods. RESULTS: The mean number of all drugs for home care patients (n = 512) was 15. The odds of drug-induced impairment of renal function (RENBASE D, P = .020) and medication-related risk loads for bleeding (PHARAO D, P = .001), anticholinergic effects (PHARAO D, P = .009), and constipation (PHARAO D, P = .003) decreased significantly in the intervention group compared with usual care. The intervention also reduced the odds of using PIMs (Meds75+ D, P = .005). There were no significant changes in drug-drug-interactions or number of drugs. CONCLUSIONS AND IMPLICATIONS: FIMA intervention improved the medication quality of home care patients. Risks for renal failure, anticholinergic effects, bleeding, constipation, and the use of PIMs were reduced significantly.
引用
- Auvinen KJ, Räisänen J, Voutilainen A, et al. Interprofessional Medication Assessment has Effects on the Quality of Medication Among Home Care Patients: Randomized Controlled Intervention Study. J Am Med Dir Assoc. 2020. PMID: 32893136. doi:10.1016/j.jamda.2020.07.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。